Market Cap (In USD)
4.47 Million
Revenue (In USD)
458.54 Thousand
Net Income (In USD)
-15.98 Million
Avg. Volume
4628.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.026-0.29
- PE
- -1.19
- EPS
- -0.08
- Beta Value
- 1.266
- ISIN
- CA21872J3073
- CUSIP
- -
- CIK
- -
- Shares
- 47097332.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Joel Shacker
- Employee Count
- -
- Website
- https://core1labs.com
- Ipo Date
- 2015-06-25
- Details
- Core One Labs Inc. operates as a biotechnology research and technology life sciences company. The company focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. Its CannaStrips technology produces infused strips that allow for bioavailability of cannabis constituents. The company also offers consulting, financing, and micro cultivation services, as well as operates medical and wellness clinics. In addition, it provides natural health products; and news dissemination services. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
More Stocks
-
ATOGFAUTO1 Group SE
ATOGF
-
MSTCLTDMSTC Limited
MSTCLTD
-
NMDCNMDC Limited
NMDC
-
WOLV
-
HRZ
-
8119Clientron Corp.
8119
-
KLSO
-
ADN